Transaction · 0001622058-26-000020

Troendle August J.

Troendle August J., PRES, CEO, reported an open-market or private sale at Medpace Holdings, Inc. involving 154.000000 shares for an estimated $95572.40. Reported holdings after the transaction were 389302.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SPRES, CEO
MEDPMedpace Holdings, Inc.
Filing timeSep 29
Trade dateSep 25, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded0.04%Shares sold ÷ (holdings after + shares sold). Estimated position before: 389,456 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$615.94
Pre-filing
1mo ago +0.5%1w ago -0.6%1d ago +0.8%
Returns since
7d30d90d180d1y

MEDP price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
MEDP since 2026-09-29Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001622058-26-000020
Common Stock
Transaction date
Sep 25, 2026
Filed Sep 29, 2026, 08:13 PM · 4d delay
Shares
154 sh
$620.60 per share
Estimated value
-$95.5k
Computed from shares × price
Holdings after
389k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Repeat Seller
+6score
Filing-only score

+6

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President & CEO

Officer YesDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    The transaction(s) reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

  2. F2

    The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $621.20. The Reporting Person undertakes to provide full pricing information to…

  3. F3

    The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Report…

Original filing · 0001622058-26-000020
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

MEDP